Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

Breast

Volumn 19, Issue 5, 2010, Pages 388-395

  Phillips, Kelly Anne ^a   Ribi, Karin ^b   Sun, Zhuoxin ^c   Stephens, Alisa ^d   Thompson, Alastair ^e   Harvey, Vernon ^f   Thürlimann, Beat ^g,h   Cardoso, Fatima ⁱ   Pagani, Olivia ^h,j   Coates, Alan S ^k   Goldhirsch, Aron ^j   Price, Karen N ^l   Gelber, Richard D ^l   Bernhard, Jürg ^m  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b International Breast Cancer Study Group Coordinating Center   (Switzerland)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

^f Auckland City Hospital   (Australia)

^g KANTONSSPITAL   (Switzerland)

^h SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

ⁱ JULES BORDET INSTITUTE   (Belgium)

^j ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^k UNIVERSITY OF SYDNEY   (Australia)

^l FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^m UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

Aromatase inhibitor; Breast cancer; Cognitive function; Letrozole; Quality of life; Tamoxifen

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ESTROGEN RECEPTOR; LETROZOLE; NEUROLEPTIC AGENT; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; ALCOHOL CONSUMPTION; ANXIETY DISORDER; ARTICLE; ATTENTION; AUSTRALIA; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DISTRESS SYNDROME; DOUBLE BLIND PROCEDURE; DRUG DOSE SEQUENCE; EUROPE; FATIGUE; FEMALE; HEAD INJURY; HUMAN; LEARNING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEMORY CONSOLIDATION; MENTAL DISEASE; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; NEW ZEALAND; PARTIAL MASTECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF REPORT; TASK PERFORMANCE; TREATMENT DURATION; TUMOR VOLUME; VISUAL DISCRIMINATION; WORKING MEMORY;

EID: 77957161009     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2010.03.025     Document Type: Article

References (31)

1. Phillips K.A., Bernhard J. Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst 2003, 95:190-197.
2. Vardy J., Wefel J.S., Ahles T., Tannock I.F., Schagen S.B. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008, 19:623-629.
3. Sherwin B.B. Estrogen and cognitive functioning in women. Endocr Rev 2003, 24:133-151.
4. Ciocca D.R., Roig L.M. Estrogen receptors in human non-target tissues: biological and clinical implications. Endocr Rev 1995, 16:35-37.
5. Sumner B.E., Grant K.E., Rosie R., Hegele-Hartung C., Fritzemeier K.-H., Fink G. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Res Mol Brain Res 1999, 73:119-128.
6. Jenkins V., Atkins L., Fallowfield L. Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition?. Eur J Cancer 2007, 43:1342-1347.
7. Castellon S.A., Silverman D.H., Ganz P.A. Breast cancer treatment and cognitive functioning: current status and future challenges in assessment. Breast Cancer Res Treat 2005, 92:199-206.
8. Jenkins V., Shilling V., Fallowfield L., Howell A., Hutton S. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology 2004, 13:61-66.
9. Bender C.M., Sereika S.M., Brufsky A.M., Ryan C.M., Vogel V.G., Rastogi P., et al. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause 2007, 14:995-998.
10. Jenkins V., Ambroisine L.M., Atkins L., Cuzick J., Howell A., Fallowfield L.J. Effects of anastrozole on cognitive performance in postmenopausal women: a randomized, double-blind chemoprevention trial (IBIS II). Lancet Oncol 2008, 9:953-961.
11. Schilder C.M., Seynaeve C., Beex W.B., Linn S.C., Boogerd W., Gundy C.M., et al. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol 2010, 28. 1294-300.
12. Hermelink K., Henschel V., Untch M., Bauerfeind I., Lux M.P., Munzel K. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients. Cancer 2008, 113:2431-2439.
13. Collins B., Mackenzie J., Stewart A., Bielajew C., Verma S. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study. Psychooncology 2009, 18:811-821.
14. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 2005, 353:2747-2757. BIG 1-98 Collaborative Group.
15. Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. N Engl J Med 2009, 361:766-776. BIG 1-98 Collaborative Group.
16. Vardy J., Wong K., Yi Q.L., Park A., Maruff P., Wagner L., et al. Assessing cognitive function in cancer patients. Support Care Cancer 2006, 14:1111-1118.
17. Falleti M.G., Maruff P., Collie A., Darby D.G., McStephen M. Qualitative similarities in cognitive impairment associated with 24h of sustained wakefulness and a blood alcohol concentration of 0.05%. J Sleep Res 2003, 12:265-274.
18. Snyder P.J., Werth J., Giordani B., Caveney A.F., Feltner D., Maruff P. A method for determining the magnitude of change across difference cognitive functions in clinical trials: the effects of acute administration of two different doses of alprazolam. Hum Psychopharmacol 2005, 20:263-273.
19. Collie A., Darby D., Maruff P. Computerized cognitive assessment of athletes with sports related head injury. Br J Sports Med 2001, 35:279-302.
20. Phillips K.A., Faletti M., Maruff P. The acute effects of adjuvant chemotherapy for breast cancer on cognition. Eur J Cancer 2006, 4/2(Suppl):94. abstr 173.
21. Broadbent D.E., Cooper P.F., Fitzgerald P., Parkes K.R. The cognitive failures questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982, 21:1-16.
22. Goldberg D. General health questionnaire (GHQ-12) 1992, NFER-Nelson, Windsor, UK.
23. Mendoza T.R., Wang X.S., Cleeland C.S., Morrissey M., Johnson B.A., Wendt J.K., et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 1999, 85:1186-1196.
24. Bernhard J., Hürny C., Coates A.S., Peterson H.F., Castiglione-Gertsch M., Gelber R.D., et al. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group. Ann Oncol 1997, 8:25-835. Erratum in: Ann Oncol 1998;9:231.
25. Maruff P., Thomas E., Cysique L., Brew B., Collie A., Snyder P., et al. Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol 2009, 24(2). 165-78.
26. Hocking R.R. The analysis and selection of variables in linear regression. Biometrics 1976, 32:1-50.
27. Geerlings M.I., Launer L.J., de Jong F.H., Ruitenberg A., Stijnen T., van Swieten J.C., et al. Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study. Ann Neurol 2003, 53:607-615.
28. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's health initiative memory study: a randomised controlled trial. J Am Med Assoc 2003, 289:2663-2672.
29. Chen D., Wu C.F., Shi B., Xu Y.M. Tamoxifen and toremifene cause impairment of learning and memory function in mice. Pharmacol Biochem Behav 2002, 71:269-276.
30. Alejandre-Gomez A., Garcia-Segura L.M., Gonzalez-Burgos I. Administration of an inhibitor of estrogen biosynthesis facilitates working memory acquisition in male rats. Neurosci Res 2007, 58:272-277.
31. Aydin M., Yilmaz B., Alcin E., Nedzvetsky V.S., Sahin Z., Tuzcu M. Effects of letrozole on hippocampal and cortical catecholaminergic neurotransmitter levels, neural cell adhesion molecule expression and spatial learning and memory in female rats. Neuroscience 2008, 151:186-194.